Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic and Immunological Significance of CXCR2 in Ovarian Cancer: A Promising Target for Survival Outcome and Immunotherapeutic Response Assessment.

Disease markers - 1 Jan 2021

Ji Haizhou, Ren Mi, Liu Tongyu, Sun Yang

Abstract excerpt

OBJECTIVE: Uncovering genetic and immunologic tumor features is critical to gain insights into the mechanisms of immunotherapeutic response. Herein, this study observed the functions of CXCR2 in prognosis and immunology of ovarian cancer. METHODS: Expression, prognostic significance, and genetic mutations of CXCR2 were analyzed in diverse cancer types based on TCGA and GTEx datasets. Associations of CXCR2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Follow-Up Studies
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immune Checkpoint Inhibitors

Share to Microsatellite Instability

Share to Ovarian Neoplasms

Share to Receptors, Interleukin-8B

Share to Survival Rate

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 34840630
DOI: 10.1155/2021/5350232
PMCID: PMC8626184

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic and Immunological Significance of CXCR2 in Ovarian Cancer: A Promising Target for Survival Outcome and Immunotherapeutic Response Assessment.PMID 34840630Read ↗

Bioinformatic Analysis of the CXCR2 Ligands in Cancer ProcessesSemantic proximity Read ↗

Identifying ITGB2 as a Potential Prognostic Biomarker in Ovarian CancerSemantic proximity Read ↗

Identification of CXCL10-Relevant Tumor Microenvironment Characterization and Clinical Outcome in Ovarian CancerSemantic proximity Read ↗

CXCR4 orchestrates the TOX-programmed exhausted phenotype of CD8+ T cells via JAK2/STAT3 pathway.Semantic proximity Read ↗

Integrative Bioinformatics Analysis of CXCR-4 (C-X-C motif chemokine receptor 4): Expression Pattern and Role in Breast Cancer ProgressionSemantic proximity Read ↗

Comprehensive analysis reveals XCL2 as a cancer prognosis and immune infiltration-related biomarkerSemantic proximity Read ↗

Comprehensive analysis of the prognostic value and immune function of chemokine-CXC receptor family members in breast cancer.Semantic proximity Read ↗

Activation of the Chemokine Receptor 3 Pathway Leads to a Better Response to Immune Checkpoint Inhibitors in Patients with Metastatic Urothelial CarcinomaSemantic proximity Read ↗

Immunogenomic Analyses of Advanced Serous Ovarian Cancer Reveal Immune Score is a Strong Prognostic Factor and an Indicator of Chemosensitivity.Semantic proximity Read ↗

At the Bench: Pre-clinical evidence for multiple functions of CXCR4 in cancer.Semantic proximity Read ↗

Systematic pan-cancer analysis reveals XCR1 as a Prognostic and Immunological BiomarkerSemantic proximity Read ↗

Study on correlation between CXCL13 and prognosis and immune characteristics of Ovarian CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.